Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system
Authors:
- Martin J. SnowdenMSMartin J. Snowden
- Babur Z. ChowdhryBCBabur Z. Chowdhry
- Ian C. AshurstIAIan C. Ashurst
- Craig J. Davies-CuttingCDCraig J. Davies-Cutting
- Trevor RileyTRTrevor Riley
- 1 June 2001
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 221 (1-2) , 165-174
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environmentsInternational Journal of Pharmaceutics, 2000
- Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus InhalersCanadian Respiratory Journal, 1999
- Effect of shear schedule on particle size, density, and structure during flocculation in stirred tanksPowder Technology, 1998
- Surfactant Dissolution and Water Solubilization in Chlorine-Free Liquified Gas PropellantsDrug Development and Industrial Pharmacy, 1998
- The Effect of Surfactant and Solid Phase Concentration on Drug Aggregates in Model Aerosol Propellent SuspensionsJournal of Pharmacy and Pharmacology, 1996
- Rheology of Model Aerosol SuspensionsJournal of Pharmacy and Pharmacology, 1993